Site Logo
Orphazyme complete enrolment in Phase II clinical trial
2019-08-30 08:08:55

Orphazme have just announced their interim report detailing their activities and achievements for the first half of 2019 and we’re thrilled about one of their milestones: they have completed enrolment in their Phase II Gaucher clinical trial of arimoclomol which was initiated in June 2018 across 9 centres in India, involving approximately 40 patients.

We look forward to sharing results from this in the first half of 2020.

You can read the full report here https://www.orphazyme.com/news-feed/2019/8/28/orphazyme-announces-interim-report-first-half-2019